# LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients

> **NCT06576635** · NA · RECRUITING · sponsor: **University of Illinois at Chicago** · enrollment: 29 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Paclitaxel
- **DRUG:** Gemcitabine
- **DRUG:** Pemetrexed
- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT06576635
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06576635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06576635, "LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06576635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*